PILOT DATASET / TRANSACTION REVIEW
Explore insider transactions.
New filings and insider history →
Search the pilot by company, ticker, insider or accession. Every imported transaction stays visible, including excluded securities and unresolved records.
120 transactions assessed62 filings154 calculated checkpoints
Data cutoff: 2026-11-04 12:55:26 UTC. Partial includes missing prices or horizons that have not matured. Counts are transaction rows, not independent purchase events.
120 matching transactions · Page 1 of 4
| Company / insider | Transaction date | Filing date | Reported value* | Assessment | Returns |
|---|---|---|---|---|---|
| GAMGENERAL AMERICAN INVESTORS CO INCStark Eugene S | 2026-09-23 | 2026-09-24 | 113,750 | excludedsecurity title review; fund outside ordinary share universe | 0/14 |
| GAMGENERAL AMERICAN INVESTORS CO INCDAVIDSON SPENCER | 2026-09-23 | 2026-09-24 | 227,500 | excludedsecurity title review; no executive or director | 0/14 |
| GAMGENERAL AMERICAN INVESTORS CO INCGrassi Craig Anthony | 2026-09-22 | 2026-09-23 | 46,160 | excludedsecurity title review; fund outside ordinary share universe | 0/14 |
| GAMGENERAL AMERICAN INVESTORS CO INCPriest Jeffrey W | 2026-09-18 | 2026-09-18 | 93,840 | excludedsecurity title review; fund outside ordinary share universe | 0/14 |
| GAMGENERAL AMERICAN INVESTORS CO INCJin Samantha X. | 2026-09-17 | 2026-09-18 | 23,660 | excludedsecurity title review; fund outside ordinary share universe | 0/14 |
| GAMGENERAL AMERICAN INVESTORS CO INCJin Samantha X. | 2026-09-17 | 2026-09-18 | 47,380 | excludedsecurity title review; fund outside ordinary share universe | 0/14 |
| EMLEASTERN COGalbato Chan | 2026-09-16 | 2026-09-17 | 30,729.25 | reviewcompensation issuance review | 0/14 |
| EMLEASTERN COEVERETS JOHN | 2026-09-16 | 2026-09-17 | 26,184.25 | reviewcompensation issuance review | 0/14 |
| EMLEASTERN COMITAROTONDA JAMES A | 2026-09-16 | 2026-09-17 | 35,930.75 | reviewcompensation issuance review | 0/14 |
| EMLEASTERN COScott Peggy | 2026-09-16 | 2026-09-17 | 25,149 | reviewcompensation issuance review | 0/14 |
| GAMGENERAL AMERICAN INVESTORS CO INCStark Eugene S | 2026-09-15 | 2026-09-15 | 120,000 | excludedsecurity title review; fund outside ordinary share universe | 0/14 |
| MATWMATTHEWS INTERNATIONAL CORPNauman J Michael | 2026-09-11 | 2026-09-15 | 19,990 | partialimmature | 6/14 |
| MATWMATTHEWS INTERNATIONAL CORPNauman J Michael | 2026-08-24 | 2026-08-25 | 21,080 | partialimmature | 8/14 |
| MATWMATTHEWS INTERNATIONAL CORPNauman J Michael | 2026-08-20 | 2026-08-24 | 41,724 | partialimmature | 8/14 |
| MATWMATTHEWS INTERNATIONAL CORPNauman J Michael | 2026-08-19 | 2026-08-20 | 2,198 | partialimmature | 8/14 |
| MATWMATTHEWS INTERNATIONAL CORPRichards Aleta W. | 2026-08-14 | 2026-08-17 | 69,180 | partialimmature | 8/14 |
| INTCINTEL CORPTAN LIP BU | 2026-08-11 | 2026-08-14 | 9,999,985 | partialimmature | 8/14 |
| MATWMATTHEWS INTERNATIONAL CORPSCHAWK DAVID A | 2026-08-10 | 2026-08-10 | 118,000 | partialimmature | 8/14 |
| MATWMATTHEWS INTERNATIONAL CORPNauman J Michael | 2026-08-10 | 2026-08-12 | 45,940 | partialimmature | 8/14 |
| ETRENTERGY CORP /DE/Ropp Ralph Lewis | 2026-08-06 | 2026-08-06 | 106,080 | partialimmature | 8/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-06 | 2026-08-28 | 0 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-06 | 2026-08-28 | 0 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-06 | 2026-08-28 | 8,500,000 | reviewamendment review; no executive or director | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 1,785,000 | reviewamendment review; no executive or director | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 21,765.64 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 9,775.89 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 29,343.96 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 4,410 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 34,325.36 | excludedamendment review; not purchase acquisition | 0/14 |
| ATTOAttovia Therapeutics, Inc.GOLDMAN SACHS & CO. LLC; GOLDMAN SACHS GROUP INC; GOLDMAN SACHS ASSET MANAGEMENT, L.P.; Broad Street Principal Investments, L.L.C.; West Street Life Sciences I, L.P.; WSLS EMP OFFSHORE INVESTMENTS, L.P.; WSLS OFFSHORE INVESTMENTS, SLP; WSLS EMP ONSHORE INVESTMENTS, L.P. | 2026-08-05 | 2026-08-28 | 74,912.04 | excludedamendment review; not purchase acquisition | 0/14 |
*Shares × bulk reported price, before any original-XML precision corrections; amounts may be rounded. Open a transaction to see source details. Returns exclude dividends and costs. No insider rankings or probability estimates are inferred from this pilot.